baber/WOPTO huggingface dataset:
Patent IE-822067-L (IE)
Title: OPTICALLY UNIFORM ß-LACTAMS.
IPC: C07D317/36
Filed: 1982-08-26
Abstract: There is presented optically uniform  beta -lactams of the formulae <IMAGE>   wherein Z is a readily cleavable acyl group, R1 is amino or a group convertible into amino, R2 is hydrogen or a readily cleavable protecting group and R3 and R4 each are a lower hydrocarbon group which optionally contains oxygen and which is attached via a carbon atom, whereby these groups can also be joined with one another to form a ring, with the proviso that R1 is a readily cleavable acylamino when R2 is hydrogen, and the corresponding optical antipodes, their manufacture and use in the manufacture of antimicrobially-active  beta -lactams as well as novel intermediates usable in their manufacture.
Patent IE-902182-L (IE)
Title: Tricyclic compounds; pharmaceutical compositions
IPC: C07C237/30
Filed: 1990-06-18
Abstract: Use of compounds of formula (I) <CHEM>  wherein A represents a group selected from: <CHEM>  X represents -CH- or -N-; R<1> represents a hydrogen or halogen atom, a C1-4 alkoxy group, a C1-4 alkyl group, or a C1-4 alkyl group substituted by 1 to 3 halogen atoms; R<2> represents a hydrogen or halogen atom, a C1-4 alkoxy group, benzyloxy or a group -R<7>COOR<8> (wherein R<7> represents a single bond or a C1-7 bivalent aliphatic hydrocarbon group and R<8> represents a hydrogen atom or a C1-4 alkyl group) or a group R<7>CONR<8a>R<8b> (wherein R<8a> and R<8b> each represent a hydrogen atom or a C1-4 alkyl group, or together with the nitrogen atom to which they are attached form a 4-6 membered saturated heterocyclic ring); R<3> and R<4>, which may be the same or different each represent a hydrogen atom or a C1-4 alkyl group, or R<3> and R<4> together with the nitrogen atom to which they are attached form a 4-6 membered saturated heterocyclic ring, which may optionally contain an oxygen atom or a further nitrogen atom, which may itself be substituted by a C1-4 alkyl group; R<5> and R<6> each represent a hydrogen atom or together form a linking group between the aromatic rings, said group being selected from -CH2CH2-, -CH2O-, -OCH2-, -NHCH2, or -CH2NH;  n is zero or an integer from 1 to 3; and  p and q are each independently an integer from 1 to 4,  with the provisos that  (a) when R<5> and R<6> form a linking group, A is not -CH2 @-(CH2)n-  and  (b) when A represents a group @ @C=CH(CH2)n- and n is 1, R<1> is methyl, NR<3>R<4> is pyrrolidino and R<5> and R<6> are both hydrogen then R<2> is not hydrogen or -CH=CHCO2H, and pharmaceutically acceptable salts thereof in the manufacture of a medicament for enhancing the therapeutic effect of an antineoplastic agent.
Patent IE-842210-L (IE)
Title: Vaccine
IPC: A61P31/12
Filed: 1984-08-29
Abstract: A vaccine comprises a polypeptide with antigenic determinants, the polypeptide being derived by genetic engineering and expressed from a stable continous cell line. E.g. a preferred vaccine against herpes simplex viruses types 1 and 2 employs a mixture of gC and gD glycoproteins.
[EP0139417A1]
Patent IE-812572-L (IE)
Title: Pharmaceutical preparation
IPC: A61K31/43
Filed: 1981-11-03
Abstract: Pharmaceutical preparations for veterinary use comprise a 6 beta - halopenicillanic acid as such or a salt thereof or an ester thereof which is hydrolyzable in vivo or a salt of such an ester together with one or more beta - lactam antibiotics (e.g. specified penicillins or cephalosporins), as such or in the form of their pro-drugs, and together with a pharmaceutically acceptable, non-toxic carrier and/or auxiliary agent. The preparation may contain other active ingredients and is preferably compounded with an oleaginous carrier. The preparation is suitable for intramammary use for the treatment of bovine mastitis and for similar local treatment of cavities.
[GB2087236A]
Patent NO-762841-L (NO)
Inventor: MOORE A J
IPC: B30B1/32
Filed: 1976-08-17
Abstract: Presser.
Patent NO-801391-L (NO)
Title: Plastroerkopling.
Inventor: RUOHONEN LEO
IPC: F16L/
Filed: 1980-05-09
Abstract: Foreliggende oppfinnelse angår en plastrørkop-ling, beregnet spesielt for plastrør med tykk vegg ved hjelp av hvilken kopling plastrr (3) kan koples til metalldeler som f.eks. metallrør og til hvilken hører et spindellegeme forsynt med en boring som motsvarer rørets (3) tykkelse, en spennmutter (8) og spennorgan.Oppfinnelsen karakteriseres ved at der i spindellegemet (1) mellom en med gjenger forsynt mer vidstrakt del (4) og en del som motsvarer rørets (1) tykkelse,. er anordnet en kondel (5) og at spennorganet består f.eks. av en messingspennring hvis fremkant er konisk i samsvar med kondelen (5), mens dens bakre kant mot hvilken spennmutteren (8) presser, er en ringflate som strekker seg vinkelrett på aksen.
Patent NO-813380-L (NO)
Inventor: BURCHART JOACHIM
IPC: G07D1/00
Filed: 1981-10-06
Abstract: A money dispensing device for use in safes or the like which transfers money from a security area to a dispensing point. A powered drawer transfers money from the security area to the dispensing point. The dispensing point is provided with a door, which is automatically controlled, such that the door opens only when sensors indicate that the drawer has reached the end of the dispensing point, and after opening, the door closes only when sensors indicate that the drawer is empty.
Patent NO-820489-L (NO)
Inventor: BALZER DIETER
IPC: E21B43/22
Filed: 1982-02-17
Abstract: 1. A process for the recovery of largely emulsion-free oil from an underground deposit of medium or high salinity by forcing into an injection bore a 0.1 to 20% solution or dispersion in formation water of a carboxymethylated oxyethylate surfactant of the formula R-(OCH2 CH2 )n -OCH2 -COOM where R is a linear or branched aliphatic radical of 6 to 20 carbon atoms or an alkylaromatic radical of 3 to 16 carbon atoms in the alkyl moiety, n is 1 to 30 and M is an alkali metal, alkaline earth metal or ammonium ion and the degree of carboxymethylation is incomplete, the surfactant I being selected so that the phase inversion temperature of the crude oil/formation water/surfactant/optional additives system is 0 to 10 degrees C above the temperature of the deposit, characterised in that the degree of carboxymethylation of the surfactant, i.e. the anionic fraction, is 90 to 100% of the total.
Patent NO-832667-L (NO)
Inventor: NICKISCH KLAUS
IPC: C07J31/00
Filed: 1983-07-21
Abstract: 7 alpha -acylthio-15,16-methylene-3-oxo-17 alpha -pregna-1,4-diene-21,17-carbolactones of the formula <CHEM>  wherein the 15,16-methylene group can be in the  alpha - or  beta - configuration, and  R is a lower alkyl residue,  have altialdosterone activity. They are prepared from corresponding  DELTA <4>-unsaturated compounds by chemical or microbiological 1,2-dehydrogenation.
Patent NO-852493-L (NO)
Inventor: GANGULI KESHAB LAL
IPC: C11C3/12
Filed: 1985-06-20
Abstract: The invention provides a nickel/alumina/silicate catalyst, with an atomic ratio of nickel/aluminium between 20 and 2, a nickel/silicate ratio between 20 and 1, an active nickel surface area between 70 and 150 m<sup>2</sup>/g nickel and an average pore size, depending on the above atomic ratio, between 4 and 20 nanometers. Preferably the nickel/aluminium atomic ratio is between 10 and 4 and the nickel/silicate ratio between 12 and 3. Preferably the catalyst has a specific porous structure.The invention also provides a method for preparing the catalyst by a two step process involving precipitating nickel ions and adding during a second, so-called ageing step a soluble aluminium compound and optionally the silicate. The silicate is preferably added during a second ageing step.The catalyst is useful for hydrogenating unsaturated organic compounds in particular oils.
Patent NO-865321-L (NO)
Inventor: OWER RONALD DEAN
IPC: A01G1/04
Filed: 1986-12-29
Abstract: The invention pertains to culturing ascocarps or fruitbodies of species of the genus Morchella. Mycelia are provided nutrients and subsequently produce sclerotia. Sclerotia store sufficient nutrient to supply the ascocarps that are developed later. The mycelia and attendant sclerotia are established in a nutrient poor substratum. The fungus is induced to give rise to ascocarp development by initially maintaining the fungus in an environment that is poor in exogenous nutrients, and by exposing the fungus to a high level of water. After induction, primordia appear. The period from primordia appearance until midway to maturation of the fruitbodies represents a critical period during which the fruitbodies are prone to abort. During this critical period, particular attention is directed to maintaining favorable conditions. The fruitbodies, which may be grown to maturation, are harvested.
Patent NO-881019-L (NO)
Inventor: BARTHELEMY PASCAL
IPC: C08G77/42
Filed: 1988-03-08
Abstract: Novel heat-resistant maleimido polymers, well adopted for the production of molded/laminated shaped articles, are copolymerizates of (a) a hydrocarbyl N,N'-bis(maleimide); (b) a diamine containing a diorganopolysiloxane bridge; optionally, (c) an N,N'-bis(maleimide) containing a diorganopolysiloxane bridge; optionally, (d) at least one other comonomer copolymerizable therewith; and, optionally, (e) a catalyst therefor.
Patent NO-881049-L (NO)
Inventor: PUTZIG DONALD EDWARD
IPC: C09K8/68
Filed: 1988-03-09
Abstract: Water-soluble N,N-bis-(2-hydroxyethyl)-glycine/metal chelates represented by the formula: <CHEM> wherein R is H or alkyl (1-12C); M is Ti or Zr; k is a number in the range between 0 and 1, p is a number in the range between 1 and 2, and k + p = 2 (in particular embodiments: k = 1 and p = 1; k = 0 and p = 2; and k = 0.5 and p = 1.5). The chelates can be used as cross-linking agents in hydraulic fracturing fluids and in gels that are used for selectively plugging permeable zones in subterranean formations or for plugging subterranean leaks.
Patent NO-882551-L (NO)
Inventor: BUNTAIN IAN GEORGE
IPC: C07D231/44
Filed: 1988-06-09
Abstract: N-Phenylpyrazole derivatives of the formula: <CHEM>  wherein R<1> represents cyano, nitro, halogen, acetyl or formyl: R<2> represents R<5>SO2, R<5>SO or R<5>S in which R<5> is optionally halogen substituted alkyl, alkenyl or alkynyl; R<3> represents a hydrogen atom or a group NR<6>R<7> wherein R<6> and R<7> each represent hydrogen, alkyl, alkenylalkyl, alkynylalkyl, formyl, optionally halogen substituted alkanoyl, optionally halogen substituted alkoxycarbonyl, or alkoxymethyleneamino, halogen, or R<6> and R<7> together form a cyclic imide and R<4> represents a substituted phenyl group possess arthropodicidal, plant nematocidal, anthelmintic and anti-protozoal properties; their preparation, compositions containing them and their use are described.
Patent NO-885150-L (NO)
Inventor: MIKALSEN GUNNAR MINDOR
IPC: C09B61/00
Filed: 1988-11-18
Abstract: PCT No. PCT/NO89/00119 Sec. 371 Date Jul. 15, 1991 Sec. 102(e) Date Jul. 15, 1991 PCT Filed Nov. 15, 1989 PCT Pub. No. WO90/05765 PCT Pub. Date May 31, 1990.A method is provided for recovering astaxanthin, astaxanthin carotenoids, astaxanthin esters, chitin and proteins from crustacean tissues containing such. The method comprises an initial extraction of crustacean tissue with boiling lye to form an alkaline extract and an extracted residue. The alkaline extract, upon cooling, forms separate layers from which can be recovered component protein, astaxanthin, astaxanthin carotenoids and astaxanthin esters. The lye extracted residue of chitin-containing such crustacean tissue is readily processed to provide chitin.
Patent NO-902079-L (NO)
Inventor: KUSTERMANN MARTIN
IPC: B05C5/02
Filed: 1990-05-10
Abstract: In the coating device, a covering body (1) is provided at the mouth (11) emerging from the chamber for the coating compound (10), between said mouth and the counter-roller or material web, said covering body forming, at its surface facing the mouth (11), an outlet channel (7) which leads away from the space (9) through which flows the coating compound at the coating blade (4). This outlet channel has a throttling action. Furthermore, the covering body (1) forms, with respect to the coating blade (4), a second throttling channel (8) located relatively close to the coating edge of the coating blade (4). The covering body (1) preferably ends at the outlet end of the second throttling channel (8) in a tip (16) arranged relatively close to the counter-roller or material web. Advantageously, the outlet channel (7) can be formed between a base body (5) and the covering body (1), the base body (5) ending at a distance from the coating blade (4) at most 10 mm greater than the clear width (e) of the second throttling channel (8). 
<IMAGE>
Patent NO-903212-L (NO)
Inventor: WALLACE PETER LIAM
IPC: B29C43/20
Filed: 1990-07-18
Abstract: A granular filler, suitable for incorporating in a composition for use in coating the surface of a glass mat-reinforced thermoplastic material, characterised in that the granular filler comprises (a) a particulate inorganic material, (b) from 0.1% to 10% by weight, based on the weight of the inorganic material, of fine carbon black, and (c) sufficient of a natural or synthetic latex composition to provide from 1% to 10% by weight of elastomer, and in that the granules have diameters in the range from 0.01 mm to 0.1 mm. <IMAGE>
Patent NO-913651-L (NO)
Title: System og fremgangsmaate for aa overvaake, fremvise og registrere oppblaasningsdata for ballong-kateter.
Inventor: FOOTE JERROLD L
IPC: A61B/
Filed: 1991-09-16
Abstract: Et elektronisk kontrollert spraytesystem (14) for forbindelse med et ballong-kateter (10) eller annet element av ballong-type og for automatisk å overvåke, fremvise og registrere oppblåsnlngsdata når sprøytesys-temet (14) anvendes til å oppblåse ballong-kateteret (10) eller annet element av ballong-type. En sprøyte. (16) som har en sylinder (22) og et sprøyteplungerstem-pel (24) er selektivt opererbart til å øke fluidumstrykk som tilføres ballong-kateteret (10) eller annet ballong-element ved å la plungerstempelet (24) gli ytterligere inn i sylinderen (22). Positivt trykk som tilføres ballong-kateteret (10) eller elementet" kan frigjøres ved å trekke sprøyteplungerstempelet (24) tilbake mot det bakre parti av sylinderen (22). En piezoresistiv halvleder transducer (18) som befinner seg på sylinderen (22) av sprøyten (16) avføler positivt fluidumstrykk som tilføres av sprøyten (16). Den elektriske signalutmatningen fra transduceren (18) innmates til en styreenhet (20) hvor signalet digitalt behandles for derved å utlede og registrere derfra elektroniske data som representerer størrelsen av tilført fluidumstrykk, og for derved også å utlede lengden av tid som positivt fluidumstrykk tilføres og elektroniske data som representerer denne informasjon blir automatisk fremvist og registrert. Styreenheten (20) er også programmerbar til å tillate valgfritt valg og innmatning av forskjellige styreparametre, slik som et maksimum positivt oppblåsningstrykk som skal tilføres, maksimum varighet for tilføring av positivt oppblåsningstrykk, initialisering av dato og tid for en oppblåsningsprosedyre og/eller henting og fremvisning av oppblåsnlngsdata som er tidligere registrert for hvilken som helst tidligere oppblåsning av ballong-kateteret (10) eller annet ballong-element.
Patent NO-914765-L (NO)
Inventor: DELOT JOSE
IPC: B05D1/18
Filed: 1991-12-04
Abstract: The present invention relates to a method, a housing and a plant for the continuous/intermittent coating of objects by dipping them in a bath of liquid coating product contained in a housing provided with aligned inlet and outlet. The method is characterized in that the integrity of the liquid coating product is permanently preserved, whether it be the bath situated inside said housing or the liquid product circulating outside said housing. The invention applies particularly to the specific case of galvanisation of metal objects from products based on metal or metal alloy, but also to plants allowing to apply, in cold or hot conditions, a liquid coating product of any nature such as certain resins or paints, on objects whether they are metal objects or not.
Patent NO-920942-L (NO)
Inventor: MICHEL JAMES L
IPC: C07K16/00
Filed: 1992-03-11
Abstract: A vaccine capable of protecting a recipient from infection caused by group B Streptococcus. The vaccine is formed by conjugating (a) a polysaccharide conjugated to (b) a protein; wherein both the polysaccharide and the protein are characteristic molecules of the group B Streptococcus.
Patent NO-932552-L (NO)
Inventor: JALKANEN MARKKU TAPANI
IPC: C12Q/
Filed: 1993-07-14
Abstract: A method for detecting a potentially detrimental transformation of cells of an organism. The method comprises determining the content of soluble syndecan in a sample of body fluid from the organism, and comparing the determined syndecan content with a reference syndecan content from a reference fluid of the same type.
Patent NO-941547-L (NO)
Inventor: MAIBACH HANS-DIETER
IPC: E01F9/588
Filed: 1994-04-27
Abstract: There is described a support socle (1) of trapezoidal cross-section, which comprises a base (2), two side walls (3, 4) and an upper side (5), having mutually complementary first and second coupling elements (15, 19) to which adjacent support socles (1, 1') can be coupled. According to the invention, provision is made for each side wall (3 and 4) to exhibit a plane wall section (10) which merges into the base (2) at an acute angle ( alpha ), and for a concave transition region (11) forming a step to adjoin the plane wall section (10), said transition region being followed by a second plane wall section (12). <IMAGE>
Patent NO-953990-L (NO)
Inventor: YANAGISAWA HIROAKI
IPC: C07D271/07
Filed: 1995-10-06
Abstract: Compounds of formula (I) : <CHEM> in which: R<1> is hydrogen or alkyl; R<2> is alkylene; R<3> is hydrogen, alkyl, alkoxy, alkylthio, halogen, nitro group, amino group, monoalkylamino, dialkylamino, aryl, or aralkyl; X is aryl, or aromatic heterocyclic; Y is oxygen, sulfur or a group of formula >N-R<4>, in which R<4> is hydrogen, alkyl or acyl; and Z is a group of formula (Za), (Zb), (Zc) or (Zd) : <CHEM>   <CHEM> and salts thereof can be used to treat or prevent are included those arising from hyperlipidemia, hyperglycemia, obesity, impaired glucose tolerance (IGT), insulin resistant non-IGT (NGT), non-diagnostic glucose tolerance, insulin resistance, diabetic complications, fatty liver, polycystic ovary syndrome (PCOS) and gestational diabetes mellitus (GDM); in addition the compounds of the present invention have aldose reductase inhibitory activity.
Patent NO-971953-L (NO)
Inventor: HEYDEN ERIC VAN DER
IPC: H01R13/24
Filed: 1997-04-25
Abstract: PCT No. PCT/IB95/00883 Sec. 371 Date Jun. 30, 1997 Sec. 102(e) Date Jun. 30, 1997 PCT Filed Oct. 17, 1995 PCT Pub. No. WO96/13926 PCT Pub. Date May 9, 1996A cradle connector for a radio-telephone base station has a plurality of terminals mounted in insulative housings the terminal interconnected by a shorting bar inmoulded to the housing. The terminals have spring section and contacts that are depressible against action of the spring to allow relatively large tolerances in the positioning of the telephone with respect to the base station. The contacts have extensions that abut against the shorting bar when the connector is disconnected, whereby one of the terminals is connected to ground so that electrostatic discharges do not damage the base station circuitry. Certain extensions can be removed for some of the terminals if such terminals should not be grounded (e.g. power terminals). The shorting bar could be made of wire that interconnects a plurality of housings during manufacturing and handling for reducing the cost thereof. The cradle connector is thus compact, cost-effective and protected against electrostatic discharge.
Patent NO-971987-L (NO)
Inventor: OLSSON BERT-AAKE
IPC: B65D81/02
Filed: 1997-04-29
Abstract: A transfer device for aseptic and automatic transfer of filled, unsealed pharmaceutical containers (2) which comprises a transport vehicle (11) with a vertically adjustable platform (12) supporting a transportable and sealable chamber (1). The chamber (1) comprises an upper part (8) provided with a protective-gas inlet (7), a lower part (9) provided with a frame (13) for supporting the containers (2), a closable opening (14), and an intermediate, substantially horizontal flow distributor (10).
Patent NO-974708-L (NO)
Inventor: BARDSLEY HAZEL JUDITH
IPC: C07D211/60
Filed: 1997-10-10
Abstract: Levobupivacaine is useful as an anaesthetic in pregnant women. For this or other purposes, it may be formulated in a relatively high concentration, e.g. above 0.75 %.
Patent NO-985775-L (NO)
Inventor: M LLER HANS RUDOLF
IPC: B01J23/42
Filed: 1998-12-10
Abstract: Preparation of aminocyanoacetamide (I) comprises reacting cyanoacetamide with nitrites at pH 2 to give nitrosocyanoacetamide, followed by catalytic hydrogenation.
Patent NO-992275-L (NO)
Inventor: BENKER THOMAS
IPC: B60G99/00
Filed: 1999-05-11
Abstract: The invention relates to a tilt control for the superstructure of a rail vehicle, that includes a transversal acceleration sensor and a tilt control device controlled therefrom for tilting the superstructure along its longitudinal axis in relation to the running gear or the bogie supporting the superstructure. A low-pass filter is connected in the signal path between the transversal acceleration sensor and the tilt control device. In order to at least amply compensate the operation time of the low-pass filter, a steady state member is connected in the signal path between the transversal acceleration sensor and the low-pass filter, whose output signal is selected at least in the middle segment of a predetermined measuring value of the transversal acceleration values to be detected in such a way that the transversal acceleration in the superstructure remains almost constant in said segment.
Patent NO-994924-L (NO)
Inventor: KNUTZON DEBORAH
IPC: A23K1/00
Filed: 1999-10-08
Abstract: The present invention relates to a fatty acid DELTA5-desaturase able to catalyze the conversion of dihomo-gamma-linolenic acid to arachidonic acid. Nucleic acid sequences encoding a DELTA5-desaturase, nucleic acid sequences which hybridize thereto, DNA constructs comprising a DELTA5-desaturase gene, and recombinant host microorganism or animal expressing increased levels of a DELTA5-desaturase are described. Methods for desaturating a fatty acid at the DELTA5 position and for producing arachidonic acid by expressing increased levels of a DELTA5 desaturase are disclosed. Fatty acids, and oils containing them, which have been desaturated by a DELTA5-desaturase produced by recombinant host microorganisms or animals are provided. Pharmaceutical compositions, infant formulas or dietary supplements containing fatty acids which have been desaturated by a DELTA5-desaturase produced by a recombinant host microorganism or animal also are described.
Patent NO-995410-L (NO)
Inventor: JOHANSSON JOHAN
IPC: B27L1/00
Filed: 1999-11-04
Abstract: A machine for root reduction of logs comprising a framework (1), a support device (2) arranged on the framework, logs being placeable on the support device in a position with a root end portion of the log (7) in question protruding freely from the support device, and a cutter (3) for processing the root end portion of the log protruding from the support device. The support device (2) comprises means (4) for causing the log to rotate while the root end portion is being processed. The support device (2) and the rotation means (4) form a unit (5), which is movably connected to the framework, and this unit is operable, by means of a power exerting arrangement (6), between different positions wherein a log supported on the support device (2) is located on different levels in the machine.